October 13, 2021 | Highland, MD – The Jayne Koskinas Ted Giovanis Foundation for Health and Policy has extended prior JKTGF funded research to Heiko Enderling, Ph.D., a faculty member of Moffitt Cancer Center, to support his work personalizing radiation therapy to better fight breast cancer.
It is now widely recognized that breast cancer therapy should be tailored to individual patients. While patient-specific data has affected the decision for use of chemotherapy, it has yet to impact radiation therapy, the single most used therapeutic treatment in oncology.
This research seeks to decipher the architecture of the tumor-immune ecosystem in biopsy tissues to identify the optimal radiation protocol – on a per-patient basis – to induce robust immunity and eradicate the tumor.
“Radiation therapy is the most used therapy for fighting breast cancer, yet no clinical trials have attempted to individualize it,” said Ted Giovanis, founder and president of the JKTG Foundation.
“Heiko’s research has challenged current practice with exciting results, and the Foundation is pleased to further support his work so future breast cancer patients benefit from individualized treatment and better outcomes.”
Featured news
JKTG Foundation President and Founder, Ted Giovanis, Gives $35M to Study the Most Common Cause of Cancer Death: Metastasis
The Foundation is excited to announce today the creation of the Giovanis Institute for Translational Cell Biology, with a $35 million gift from researcher, philanthropist and race car driver Ted Giovanis.
Ted’s Take: Offense or Defense? When Regulations Become Two-Way Players
Legislation sets out the law, but it is in fact the regulatory agencies that interpret that law through regulations.
Ted’s Take: Priorities Should Inform Policy Decisions and Politics
Setting priorities is important. It helps get things accomplished particularly when there are multiple tasks to do. It gives order to those tasks we want to accomplish.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133